Abstract:Alteration of the lung microbiome has been observed in several respiratory tract diseases. However, most previous studies were based on 16S ribosomal RNA and shotgun metagenome sequencing; the viability and functional activity of the microbiome, as well as its interaction with host immune systems, have not been well studied. To characterize the active lung microbiome and its associations with host immune response and clinical features, we applied metatranscriptome sequencing to bronchoalveolar lavage fluid (BALF) samples from 25 patients with chronic obstructive pulmonary disease (COPD) and from nine control cases without known pulmonary disease. Community structure analyses revealed three distinct microbial compositions, which were significantly correlated with bacterial biomass, human Th17 immune response, and COPD exacerbation frequency. Specifically, samples with transcriptionally active Streptococcus, Rothia, or Pseudomonas had bacterial loads 16 times higher than samples enriched for Escherichia and Ralstonia. These high-bacterial-load samples also tended to undergo a stronger Th17 immune response. Furthermore, an increased proportion of lymphocytes was found in samples with active Pseudomonas. In addition, COPD patients with active Streptococcus or Rothia infections tended to have lower rates of exacerbations than patients with active Pseudomonas and patients with lower bacterial biomass. Our results support the idea of a stratified structure of the active lung microbiome and a significant host-microbe interaction. We speculate that diverse lung microbiomes exist in the population and that their presence and activities could either influence or reflect different aspects of lung health.IMPORTANCE Recent studies of the microbiome proposed that resident microbes play a beneficial role in maintaining human health. Although lower respiratory tract disease is a leading cause of sickness and mortality, how the lung microbiome interacts with human health remains largely unknown. Here we assessed the association between the lung microbiome and host gene expression, cytokine concentration, and over 20 clinical features. Intriguingly, we found a stratified structure of the active lung microbiome which was significantly associated with bacterial biomass, lymphocyte proportion, human Th17 immune response, and COPD exacerbation frequency. These observations suggest that the microbiome plays a significant role in lung homeostasis. Not only microbial composition but also active functional elements and host immunity characteristics differed among different individuals. Such diversity may partially account for the variation in susceptibility to particular diseases.

Relationship Between Lower Airway Bacterial Colonization and Lung Function in Patients with Chronic Obstructive Pulmonary Disease

Correlation Study of Quality of Life in Stable Phase in Patients with Chronic Obstructive Pulmonary Disease

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

Determination of Biomarkers in Exhaled Breath Condensation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Clinical Implications

Investigation on the Pathological Mechanism of Frequent Exacerbators With Chronic Obstructive Pulmonary Disease Based on the Characteristics of Respiratory Flora

Investigation of the Relationship Between Bacteria Pathogens in Sputum and Lung Function with Acute Exacerbations of COPD

Detection of relationship between pathogens of acute exacerbation of chronic obstructive pulmonary disease and comprehensive evaluation classification

Association between lung function impairment and inflammatory cytokines in induced sputum of patients with bronchiectasis

Changes of Bifidobacterium and Lactobacillus in Gut of Patients with COPD and Their Correlation with Acute Exacerbation Frequency

Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study

Determination and clinical implication of leukotriene B4 and tumor necrosis factor-α in condensate of exhaled breath of chronic obstructive pulmonary disease patients

Airway Bacterial and Fungal Microbiome in Chronic Obstructive Pulmonary Disease

Characteristics of the Sputum Microbiome in COPD Exacerbations and Correlations Between Clinical Indices

Comprehensive analysis of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity-A prospective, observational study

Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations

Analysis of bacterial spectrum, activin A, and CD64 in chronic obstructive pulmonary disease patients complicated with pulmonary infections

Bacterial Infection, Airway and Systemic Inflammation and Clinical Outcomes Before and after Treatment of AECOPD, a Longitudinal and Cross-Sectional Study.

Relationship between IL-8 and airway obstruction in patients with chronic obstructive pulmonarydisease

Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study

The Relationship of Macrophage Function with Receptor Expression in Patients with Chronic Obstructive Pulmonary Disease